Congenital Hyperinsulinism Chi clinical trials

Explore recruiting congenital hyperinsulinism chi clinical trials.

Also recruiting in Europe

Congenital Hyperinsulinism Chi trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Multiple Ascending Dose, Open-label, Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Activity of HM15136 Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI) (ACHIEVE)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Congenital Hyperinsulinism Chi trials by city

Congenital Hyperinsulinism Chi in Toronto Congenital Hyperinsulinism Chi in Vancouver Congenital Hyperinsulinism Chi in Montreal Congenital Hyperinsulinism Chi in Calgary Congenital Hyperinsulinism Chi in Edmonton Congenital Hyperinsulinism Chi in Ottawa Congenital Hyperinsulinism Chi in Winnipeg Congenital Hyperinsulinism Chi in Quebec City Congenital Hyperinsulinism Chi in Hamilton Congenital Hyperinsulinism Chi in Kitchener Congenital Hyperinsulinism Chi in London Congenital Hyperinsulinism Chi in Halifax Congenital Hyperinsulinism Chi in New York Congenital Hyperinsulinism Chi in Los Angeles Congenital Hyperinsulinism Chi in Chicago Congenital Hyperinsulinism Chi in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease